1. Home
  2. FURY vs GBIO Comparison

FURY vs GBIO Comparison

Compare FURY & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FURY
  • GBIO
  • Stock Information
  • Founded
  • FURY 2008
  • GBIO 2016
  • Country
  • FURY Canada
  • GBIO United States
  • Employees
  • FURY N/A
  • GBIO N/A
  • Industry
  • FURY Precious Metals
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FURY Basic Materials
  • GBIO Health Care
  • Exchange
  • FURY Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • FURY 59.1M
  • GBIO 64.8M
  • IPO Year
  • FURY N/A
  • GBIO 2020
  • Fundamental
  • Price
  • FURY $0.37
  • GBIO $0.95
  • Analyst Decision
  • FURY Strong Buy
  • GBIO Strong Buy
  • Analyst Count
  • FURY 1
  • GBIO 2
  • Target Price
  • FURY $1.10
  • GBIO $6.50
  • AVG Volume (30 Days)
  • FURY 121.7K
  • GBIO 749.9K
  • Earning Date
  • FURY 11-12-2024
  • GBIO 03-05-2025
  • Dividend Yield
  • FURY N/A
  • GBIO N/A
  • EPS Growth
  • FURY N/A
  • GBIO N/A
  • EPS
  • FURY N/A
  • GBIO N/A
  • Revenue
  • FURY N/A
  • GBIO $18,582,000.00
  • Revenue This Year
  • FURY N/A
  • GBIO $212.74
  • Revenue Next Year
  • FURY N/A
  • GBIO N/A
  • P/E Ratio
  • FURY N/A
  • GBIO N/A
  • Revenue Growth
  • FURY N/A
  • GBIO 514.08
  • 52 Week Low
  • FURY $0.32
  • GBIO $0.75
  • 52 Week High
  • FURY $0.59
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • FURY 43.79
  • GBIO 35.95
  • Support Level
  • FURY $0.36
  • GBIO $0.86
  • Resistance Level
  • FURY $0.38
  • GBIO $1.01
  • Average True Range (ATR)
  • FURY 0.02
  • GBIO 0.12
  • MACD
  • FURY 0.00
  • GBIO 0.01
  • Stochastic Oscillator
  • FURY 26.32
  • GBIO 25.13

About FURY Fury Gold Mines Limited

Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: